Inogen | INGN - Interest Expense On Debt


Inogen reported 1.03M in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 96M 6M Jun/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 1.1M Mar/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Medtronic USD 186M 10M Jun/2026
Orthofix International 4.68M 731K Sep/2025
Philips EUR 83M 26M Mar/2026
ResMed USD 8.79M 14.55M Sep/2025
Steris USD 15.8M 700K Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026